APUS
Apimeds Pharmaceuticals US, Inc.
NYSE MKT: APUS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
+0.00% today
Updated 2026-04-29
Market cap
$2.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Apimeds Pharmaceuticals US, Inc. (APUS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating cash flow | $-823114.00 | $-448167.00 | $-627790.00 | $-733526.00 |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $193542.00 | $193542.00 | $69993.00 | $0.00 |
| Free cash flow | $-823114.00 | $-448167.00 | $-627790.00 | $-733526.00 |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |